View Clinical Trial (Medical Research Study)

Effect of Cinnamon Extract on Insulin Resistance in Polycystic Ovary Syndrome - NCT00970541-70808(Clinical Trial 319570)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Baton Rouge
State:  
LA
Zip Code: 70808
Conditions: Polycystic Ovary Syndrome - Insulin Resistance
Purpose: The purpose of this study is to determine whether Cinnamon from the Cassae Plant is effective in the body as insulin could lower blood sugar levels.
Study summary: Insulin resistance is a condition in which body cells do not fully respond to the action of insulin, a hormone that controls the amount of sugar (glucose) in the blood. As a result, blood sugar levels become abnormally high. Insulin resistance is common in women with polycystic ovary syndrome (PCOS). This study involves the administration of a nutritional supplement (cinnamon extract). The cinnamon extract like regular cinnamon powder comes from the bark of Cinnamon Cassae plant. It is believed that cinnamon may act in the same way as insulin and therefore could potentially improve insulin resistance and help to lower blood sugar (glucose) levels.
Criteria: Inclusion Criteria: - 20 to 40 years of age - Have a body mass index 25-40 kg/m2 - Have a sedentary lifestyle (participated in less than 30 minutes of physical activity 3 days per week over the last 6 months) - History of irregular menstrual cycles (fewer than 6 cycles in past year) - Excess androgen (to be measured at screening) - Willing to supplement normal diet with cinnamon extract and a placebo for 12 weeks - You can stay overnight at Pennington Center three times over the next six months Exclusion Criteria: - Do not meet our diagnostic criteria for polycystic ovary syndrome - Have heart disease, lung disease, liver disease, blood disease, kidney disease, type 1 or 2 diabetes, or any other disease that in the opinion of the doctor might make you ineligible. - Have cancer (active malignancy with or without concurrent chemotherapy). - Abuse alcohol or illegal drugs. - Smoke or have smoked within the previous 6 months. No smoking will be permitted during the study. - Have donated blood within 30 days prior to randomization date. - Have a hemoglobin, hematocrit, red blood cell, or iron level below the normal lower limit at screening. - Taking medications that alter your glucose metabolism, (30 minute or more, 4 or more times per week over the past year.) - Unwilling or unable to adhere to the clinical evaluation schedule over the entire six-month follow-up period.
Study is available at: Pennington Biomedical Research Center
Baton Rouge, LA 70808
United States

Primary Contact:
Leanne Redman, Ph.D.
Email: Doctors@pbrc.edu
Phone: 225-763-2602
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.